摘要
隨著生物精神醫學的蓬勃發展，使用藥物來嘗試治療飲食障礙症的經驗提供了我們治療飲食障礙症的方向。對神經厭食症的患者而言，藥物並不是唯一的治療方法，而抗鬱劑的使用也必須在體重回復或營養狀況被矯正之後再投予為宜；使用抗鬱劑來避免體重已回復的患者的疾患復發，或者是治療患者的憂鬱、強迫等症狀是值得考慮的。抗鬱劑可在治療神經性暴食症初始就開始投予，其中選擇性血清素再吸收抑制劑因為安全性高、可同時處理憂鬱、焦思、強迫、衝動控制不良等，所以是應該被優先考慮使用，而使用三環抗鬱劑或單胺氧化酵素抑制劑時，則須注意副作用和患者自殺的危險性。為了提高飲食障礙症的緩解率，應該考慮同時併用藥物治療首其他心理社會的介入。
並列摘要
The advent of biological psychiatry has resulted in the emergence of knowledge regarding the pschopharmacotherapy eating disorders. Psychotropic medications should not be the sole treatment for anorexia nervosa. The administration of antidepressants should be assessed after body weight has been restored and nutritional status corrected. These medications should be considered for the prevention of relapse among weight-restored patients or to treat associated features of anorexia nervosa, such as depression or obsessive-compulsive disorder. As for bulimia nervosa patients, antidepressants compose an important component of an initial treatment program. Selective serotonin reuptake inhibitors are the safest antidepressants and may be helpful for patients with depression, anxiety, obsessions, or certain impulse disorders. Tricyclics and monoamine oxidase inhibitor antidepressants should be used cautiously because they carry risks of adverse effects, toxicity, or suicide attempts. The combination of psychotherapeutic interventions and pharmacotherapy causes higher remission rates and should be considered in treating patients with eating disorders. (Full text in Chinese)